KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Other Gross PP&E Adjustments (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Other Gross PP&E Adjustments data on record, last reported at $498.9 million in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 23.95% year-over-year to $498.9 million; the TTM value through Dec 2025 reached $498.9 million, down 23.95%, while the annual FY2025 figure was $498.9 million, 23.95% down from the prior year.
  • Other Gross PP&E Adjustments reached $498.9 million in Q4 2025 per EBS's latest filing, up from $493.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.2 billion in Q4 2022 and bottomed at $493.3 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 5 years is $842.9 million, with a median of $782.9 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: grew 26.78% in 2021, then tumbled 35.02% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.1 billion in 2021, then increased by 8.35% to $1.2 billion in 2022, then tumbled by 34.18% to $778.0 million in 2023, then dropped by 15.68% to $656.0 million in 2024, then decreased by 23.95% to $498.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $498.9 million in Q4 2025, $493.3 million in Q3 2025, and $508.0 million in Q2 2025.